Managers

Rice Park collects over $8.4 mln for maiden venture fund

Minneapolis-based Rice Park Capital Management has raised over $8.4 million for its debut venture fund, according to an SEC filing. The target is $50 million.

Zava inks $32 mln Series A

London-based Zava, a digital healthcare and telemedicine provider, has secured $32 million in Series A funding. HPE Growth led the round.

BlackThorn Therapeutics racks up $76 mln Series B

San Francisco-based BlackThorn Therapeutics, a neurobehavioral health company, has secured $76 million in Series B financing. The investors included Polaris Partners, Premier Partners, Scripps Research, Vertex Ventures HC, Alexandria Venture Investments, Altitude Life Science Ventures, ARCH Venture Partners, Biomatics Capital, GV, Johnson & Johnson Innovation – JJDC, Inc. and Mercury Fund. In connection with the financing, Brian Chee, a managing partner at Polaris Partners, Lori Hu, a managing director at Vertex Ventures HC and Julie Sunderland, a managing director at Biomatics Capital, joined BlackThorn’s board as directors.

Startups aim to remove stigma of mental-health treatment from workplaces

Camden Partners is seeking $50 mln for its second venture fund

Seed-stage fund managers prove connections are everything

500 Startups is raising a second fund focused on South Korean startups

Modern Fertility gathers $15 mln Series A

Modern Fertility, a provider of fertility hormone testing, has secured $15 million in Series A funding. Forerunner Ventures and Kirsten Green led the round.

Digital health firms Neurotrack procures $21 mln Series C

Redwood City, California-based Neurotrack, a digital health company, has secured $21 million in Series C funding. Khosla Ventures led the round.

Oncologie takes in $80 mln Series B

Boston and Shanghai-based Oncologie, an biopharmaceutical company, has secured $80 million in Series B financing. Nan Fung Life Sciences and Pivotal BioVentures China led the round.